MIFH
EDIT icon

Migdal Insurance & Financial Holdings’s Editas Medicine EDIT Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,407
Closed -$857K – 612
2021
Q1 		$857K Buy
+20,407
New +$1.16M 0.01% 258

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Migdal Insurance & Financial Holdings's EDIT Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 20,407 shares — an estimated $857K sold.

Migdal Insurance & Financial Holdings first reported a position in EDIT in Q1 2021 and held it in 1 quarter. The position peaked at $857K in Q1 2021. 314 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 20,407 Editas Medicine shares in Q2 2021, an estimated $857K.
  • Migdal Insurance & Financial Holdings first reported a position in Editas Medicine in Q1 2021 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's Editas Medicine position peaked at $857K in Q1 2021.
  • 314 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.